~~<i id='F5FCDE214A'><strike id='F5FCDE214A'><tt id='F5FCDE214A'><pre id='F5FCDE214A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

comprehensive

author：leisure time 2025-09-07 06:41:29 - browse：32725

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Roche drug slashes death risk in early

focus

entertainment

Wikipedia

hotspot

leisure time

knowledge

Journalist,poet,andteacherMeghanO’Rourkeonstageatthe2023STATSummit.STATWhenherlifewasupturnedbyanacc

WSS

ADCs take center stage as promising cancer treatments

Roche drug slashes death risk in early

Manchin plays down potential 3rd

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

US soldier in North Korean custody after crossing DMZ line

Questions loom on AstraZeneca cancer drug as safety concerns ebb

explore

comprehensive

focus

Novavax promises a turnaround & Lilly roils the obesity market

Biden administration sends mixed signals on US soldier who crossed into North Korea

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The problems with dementia villages

BioMarin wins approval for gene therapy to treat hemophilia A

Why a market frenzy over new weight loss drugs defies logic

As demand for Covid shots wanes, Moderna seeks its next success

Flagship, Pfizer team up in deal worth up to $7 billion

Novavax promises a turnaround & Lilly roils the obesity market

STAT Summit: The economic case for universal basic health care

entertainment

Why you get paid to donate plasma but not blood

STAT Summit: How researchers deal with rejection

House passes resolution saying Israel isn't a 'racist or apartheid state'

Readout LOUD podcast: Live from the 2023 STAT Summit

Manchin plays down potential 3rd

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Wikipedia

hotspot

leisure time

knowledge